
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RhoB CRISPR/Cas9 KO Plasmid (h) | sc-400875 | 20 µg | $397.00 |
RHOB encodes RhoB, a prenylated small GTPase in the Rho family that regulates actin cytoskeleton dynamics, endocytic trafficking, and membrane receptor turnover. RhoB cycles between GDP- and GTP-bound states to modulate signaling nodes linked to cell adhesion, migration, vesicle transport, and stress responses, with functional connections to pathways including Rho/ROCK and broader MAPK- and PI3K-influenced processes. Unlike closely related Rho GTPases, RhoB is enriched on endosomal membranes and is frequently induced by cellular stress, positioning it as a key mediator of signal compartmentalization. Altered RHOB expression or activity has been associated with cancer-related phenotypes, inflammatory signaling, and vascular biology, making it relevant for mechanistic studies of proliferation, invasion, and receptor-driven signaling.
RhoB CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RHOB gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RHOB together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RHOB open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RhoB protein expression.
This CRISPR knockout system enables efficient generation of RHOB-deficient cell models for investigation of RhoB signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.